ESGold Announces the Closing of its Brokered LIFE Offering for Gross Proceeds of C$7.2 Million
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2026-03-10 13:28

Core Viewpoint - ESGold Corp. has successfully closed a private placement offering, raising gross proceeds of C$7,264,440 to advance its Montauban Project and for general corporate purposes [1][3]. Group 1: Offering Details - The offering consisted of 10,683,000 units sold at a price of C$0.68 per unit [1]. - Each unit includes one common share and one-half of a common share purchase warrant, with each warrant allowing the purchase of one common share at C$1.00 until March 10, 2029 [2]. - Red Cloud Securities Inc. acted as the sole agent and bookrunner for the offering, receiving a cash fee of C$406,531 and 597,840 non-transferable common share purchase warrants as compensation [5]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized for advancing the Montauban Project in Québec, as well as for general working capital and corporate purposes [3]. Group 3: Regulatory Compliance - The units were issued under the listed issuer financing exemption, making them immediately freely tradeable for Canadian purchasers [4]. - The offering is subject to final approval from the Canadian Securities Exchange [6]. Group 4: Company Overview - ESGold Corp. is a fully permitted, fully funded, pre-production mining company focused on a scalable clean mining model across North and South America [8]. - The Montauban Gold-Silver Project in Quebec is under construction, with production anticipated in 2026 [8].

aTyr Pharma-ESGold Announces the Closing of its Brokered LIFE Offering for Gross Proceeds of C$7.2 Million - Reportify